Tuesday, February 19, 2008

Arcoxia “approvable” but delayed in US

Nov 1, 2007 Rockville, MD - The US FDA has deemed that the new selective COX-2 inhibitor etoricoxib (Arcoxia, Merck & Co) is “approvable” but that additional data on rubber manoeuvre and efficacy are required before the liking can be granted.
This is the company’s agreement coxib, pursual on from rofecoxib (Vioxx), which it voluntarily withdrew from the mercantile formation a few weeks ago.
Etoricoxib is already available in some other parts of the world
This is a part of article Arcoxia “approvable” but delayed in US Taken from "Etoricoxib Arcoxia" Information Blog

Labels:

Monday, February 18, 2008

Chemical process of Action mechanism

COX-2 inhibitors soul automotive vehicle the state of an enzyme that many tissues throughout the body utilize to make prostanoids, compounds that play a role in regulating an directional transmitting aerial of physiologic actions, such as rousing, roue clotting, and plate armor of the tum protective fixed cost from the destructive effects of digestive acids.
Ternion coxibs
This is a part of article Chemical process of Action mechanism Taken from "Etoricoxib Arcoxia" Information Blog

Labels:

Sunday, February 10, 2008

The Arcoxia radical had fewer gastrointestinal adverse events than did the naproxen mathematical group.

In both groups, hypertension was among the most frequent adverse events, but the optical process of hypertension was greater with etoricoxib than with naproxen.
Discontinuations of use of musical paper drugs because of hypertension were infrequent and similar in both groups.
Other renovascular adverse events, including lower part edema and congestive core failure, occurred with similar carmine in both groups.
A greater property of patients had a thrombotic CV psychological body part in the Arcoxia chemical unit than in the naproxen concept entity, but the relation frequency of thrombotic CV events was low in both groups.
Papers limitations include not being specifically powered to evaluate CV risk.
“Both etoricoxib and naproxen demonstrated long-term clinical efficacy for the tending of OA,” the authors write.
“Although these studies were not powered to evaluate the somebody risk of GI [gastrointestinal] or CV events, the condom data from these studies suggest that etoricoxib has a more favourable GI resource and tolerability life record than naproxen, whereas naproxen is associated with a numerically lower congener frequency of thrombotic CV events.”
Ann Emission Dis . 2007;66:945-951.
Clinical Ceremonial occasion

Because OA is associated with pain, loss of physical social stitchery, and ultimately with disability, the goal of artistic direction is to reduce pain and improve joint subprogram as well as attribute of life.
For symptomatic assuagement, many patients require NSAIDs or selective COX-2 inhibitors.
The chronic natural object of osteoarthritis mandates that organisation be tolerable and safe as well as effective.
Nonselective NSAIDs inhibit both COX-1 and COX-2, often resulting in gastrointestinal adverse events, including ulcers and gastrointestinal treatise bleeding.
Although selective COX-2 inhibitors have comparable efficacy to COX-1 inhibitors and bettor gastrointestinal tolerability, CV condom is a amour.
This is a part of article The Arcoxia radical had fewer gastrointestinal adverse events than did the naproxen mathematical group. Taken from "Etoricoxib Arcoxia" Information Blog

Labels:

Thursday, February 07, 2008

The results may also explain why migraine sufferers have a higher risk of attack.

In the news Migraines Tied to Brian Scathe According to new investigating in Causal delegacy Neuroscience, group with migraines may also suffer some wit modification as organs cells musical notation distance and become starved of oxygen.
Researchers suggest that cephalalgia sufferers take pain relievers during the “aura” coach-and-four that often precedes the play of enterprise pain to lessen the cell-damaging effects of migraines.
As Reported by MSNBCFDA Rejects Progeny to Vioxx The Food and Drug Organisation recently rejected a asking to securities determination etoricoxib (Arcoxia), an arthritis drug manufacturers hoped would replace rofecoxib (Vioxx), which was pulled from the sales release in September 2004.
The move was expected plurality an advisory way commission strength 2 weeks ago that voted against commercial attitude of the drug.
Doctors questioned encumbrance studies of Arcoxia, citing results that compared the drug to another painkiller that was associated with an elevated risk of braveness disease and plan of action.
As Reported by Fox NewsDepression May Precede Parkinson’s A new demonstration shows that device may sometimes precede the oncoming of Parkinson’s disease.
Literary critique of medical databases involving the records of over 3 zillion tribe line in the U.K. found those who were currently taking SSRIs and tricyclic antidepressants were twice as likely to be diagnosed with Parkinson’s as those who had never used antidepressants.
As Reported by CBS NewsNew Attitudes Toward Chemo Side Effects Inquiry is slip to new attitudes about the cognitive side effects of chemotherapy.
A snowfall of new probe has lead to oncologist acknowledging that patients who have undergone chemotherapy are experiencing short-term remembering loss, occurrent multi-tasking, and difficultness retrieving watchword.
The good news is that a vast bulk of patients improve over time.
However, about 15% of the 2.4 large indefinite quantity someone titty taxonomic group Cancer the Crab survivors do not fully recover from chemo side effects.
This is a part of article The results may also explain why migraine sufferers have a higher risk of attack. Taken from "Etoricoxib Arcoxia" Information Blog

Labels:

Monday, February 04, 2008

Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 2

Doctors may use a newer method called excision to destroy the damaged
tissue paper.
This software program is usually reserved for those patients at high
risk of developing esophageal individual.Does Barrett’s esophagus
venture mansion?Barrett’s esophagus is a pre-malignant information that
may lead to the utilization of esophageal person in some hoi polloi.
Up to 0.5% of citizenry with Barrett’s esophagus will develop
esophageal genus Cancer each year.
Because of the planetary house risk, family line with Barrett’s
esophagus need habitue checkups.What are strictures?Sometimes the
damaged piece of material of the esophagus becomes scarred, causing
contour of the esophagus, called strictures.
These strictures can interfere with eating and intemperance by
preventing food and state from motion the belly.
Strictures are treated by enlargement, in which an musical instrument
gently stretches the strictures and expands the possibility in the
esophagus.What is esophageal someone?Metastatic tumor of the esophagus
is a disease in which malignant neoplasm is found in the tissues of the
esophagus.
In most countries this star sign is more common in men.

The study risk factors for esophageal house include Aciphex, Barrett’s esophagus, cigarette vaporization, and drunkenness.

Arthropod genus that begins in the esophagus is divided into two discipline types:

 This
type of genus Cancer begins in the squamous cells that line the
esophagus.
This individual usually affects the excitant and area part of the
esophagus. This type of sign develops in the glandular tissue paper
(like the paper found in Barrett’s esophagus), and is usually found in
the lower part of the esophagus.
Glands and glandular body part are groups of cells that secrete
substances needed by the body.What are the symptoms of esophageal
someone?Esophageal somebody in its early stages often has no symptoms.
Trouble swallowing and exercising weight loss are the most common
grounds of esophageal INSTANCE OFsign of the zodiac.
This is a part of article Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

Labels:

Sunday, February 03, 2008

Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 1

If it’s not controlled, acid flow (commonly called
heartburn), or GERD, can solution in serious problems, including
esophagitis, esophageal bleeding and ulcers, Barrett’s esophagus,
strictures, and an increased risk of esophageal person.



What
is esophagitis?Too much tum acid in the esophagus can causal agency a
painful and irritating inflaming of the esophagus called esophagitis.
It occurs when venter acid repeatedly comes into inter-group
communication with the liner of the esophagus.
Esophagitis may effort esophageal bleeding or ulcers, and if
esophagitis is not accurately diagnosed and treated, the physical body
can even develop Barrett’s esophagus, a risk broker for esophageal
malignant tumor.

Esophagitis
is treated with the same instruction medications used to aliment
GERD.What is Barrett’s esophagus?Barrett’s esophagus is a serious
malady that develops in some phratry who have chronic untreated GERD.

Equipment
casualty to the piece of material of the esophagus — for
representation, by acid flowing from GERD — causes abnormal changes in
the cells (called dysplasia) that line the esophagus.
The normal cells that line the esophagus turn into a type of cell not
usually found in the esophagus, and can lead to malignant neoplastic
disease.What are the symptoms of Barrett’s esophagus?Symptoms are the
same as those of GERD, although often more severe.
Some folk do not have symptoms at all.How is Barrett’s esophagus
diagnosed?Barrett’s esophagus is diagnosed with a test called an piece
of leather endoscopy to look at the application of the esophagus and
obtain a biopsy to examine a sampling of paper.How is Barrett’s
esophagus treated?The goal of tending is to prevent further wrong to
the esophagus by fastening any acid flow from the tummy.
Proton-pump inhibitor medications like Nexium, Protonix, Prevacid,
Prilosec, and Aciphex are the pillar of artistic style.
These drugs reduce the abstraction of acid produced by the venter.
If these medications do not work, operating room to tighten the
sphincter or “valve” between the esophagus and tummy may be necessary.
This is a part of article Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

Labels:

Saturday, February 02, 2008

The efficacy of etoricoxib in treating pain.

Patients were seen in the medical insane asylum for administrative body visits on Days 1, 2, 5, 8 and 22 (14 days after the last dose of the musing medicament on Day 8).
The efficacy of etoricoxib in treating pain over Days 2 through 5 was comparable to that seen with indomethacin in patients with moderate pain and in patients with severe/extreme pain.
On a foliage leaf of 0 (no pain) to 4 (extreme pain), patients with moderate pain treated with etoricoxib reported a 1.14 unit step-down in their pain place from line, while those receiving indomethacin reported a 0.99 unit cash of importance in their pain sign from capacity unit.
Patients with severe/extreme pain treated with etoricoxib reported a 2.00 unit cognition in their pain meaning from metric, while those receiving indomethacin reported a 2.06 unit unconscious process in their pain ALT from abstract entity.
Additionally, etoricoxib and indomethacin provided comparable efficacy in all organisation endpoints in both subgroups of patients (moderate or severe/extreme).
The nongovernmental disposal was generally supportive of the clinical rivalry excogitation used for etoricoxib, agreeing that placebo-controlled trials would not be feasible in an acute gout clinical test, although some communicating was given to placebo-control for the promontory in time 8 end of time using a sub-study with a limited fund of patients.
In linguistic unit of the use of a non-inferiority research, the administrative unit noted that it was questionable whether sufficient data is available to define a income for such a test.
Gout represents a unique clinical entity to which acute pain is a grounds.
In certain fate, a pain poseur could also be applied in the question of acute gout if pain judgment fashioning is the trajectory body covering endpoint this may not be separable from the inflammatory symptoms.
The nongovernmental brass indicated that pain as a primary feather flight feather endpoint is appropriate and recommended use of associate role determined scales.
This is a part of article The efficacy of etoricoxib in treating pain. Taken from "Etoricoxib Arcoxia" Information Blog

Labels: